✦ LIBER ✦

Endpoints, patient selection, and biomarkers in the design of clinical trials for cancer vaccines

✍ Scribed by Marijo Bilusic; James L. Gulley

Publisher: Springer-Verlag
Year: 2011
Tongue: English
Weight: 265 KB
Volume: 61
Category: Article
ISSN: 0340-7004
DOI: 10.1007/s00262-011-1141-0

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Meta-analysis for the evaluation of surr

Meta-analysis for the evaluation of surrogate endpoints in cancer clinical trials

✍ Qian Shi; Daniel J. Sargent 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 254 KB

American association for the study of li

American association for the study of liver diseases endpoints conference: Design and endpoints for clinical trials in primary biliary cirrhosis

✍ Marina G. Silveira; Elizabeth M. Brunt; Jenny Heathcote; Gregory J. Gores; Keith 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 143 KB 👁 1 views

A group of multidisciplinary experts on primary biliary cirrhosis (PBC) and its complications convened on May 31, 2009, under the aegis of the American Association for the Study of Liver Diseases (AASLD) in order to identify the most appropriate design and endpoints for clinical trials of PBC based

Resampling-based methods for the analysi

Resampling-based methods for the analysis of multiple endpoints in clinical trials

✍ Peter Reitmeir; Gernot Wassmer 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 95 KB 👁 2 views

We consider multivariate tests for comparing two treatments with multiple endpoints. The test decision is drawn from the simultaneous consideration of the univariate tests for the single endpoints. A general class of these tests, called cut-o! tests, can be given, which, however, can lead to highly

Risk reduction endpoints should be part

Risk reduction endpoints should be part of the design of adjuvant therapy clinical trials for patients with melanoma : A commentary

✍ Larry Nathanson 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB 👁 2 views

Quality of life as a clinical trial endp

Quality of life as a clinical trial endpoint: determining the appropriate interval for repeated assessments in patients with advanced lung cancer

✍ Patricia J. Hollen; Richard J. Gralla; Cynthia N. Rittenberg 📂 Article 📅 2004 🏛 Springer-Verlag 🌐 English ⚖ 128 KB

The application of a two-stage design fo

The application of a two-stage design for clinical trials in patients with recurrent head and neck cancer

✍ Eisenberger, Mario A. ;Ellenberg, Susan ;Leyland-Jones, Brian ;Friedman, Michael 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 620 KB

Cytotoxic chemotherapy produces modest benefits for patients with recurrent and metastatic squamous cell carcinoma of the head and neck (SCCHN). Prospective randomized clinical trials have failed to demonstrate unequivocal superiority of aggressive multidrug regimens over single agents. Despite this